Zymeworks terminates ATM agreement with Jefferies; issues 2.715M shares upon warrant exercise at $0.0001/share

Zymeworks Inc.

Terminated Open Market Sale Agreement with Jefferies effective Nov 9, 2022; no shares were sold under it.
Issued 1,375,000 common shares on Oct 25 to a warrant holder upon partial exercise of a warrant.
Issued additional 1,340,000 common shares on Oct 27 to same warrant holder upon exercise of the remaining warrant.
Warrant exercise price was $0.0001 per share; total cash received $271.50 for both exercises.
Warrant shares issued under previously filed S-3 registration statement and prospectus supplement.

item 1.02 item 8.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Zymeworks Inc. terminated Open Market Sale Agreement with Jefferies LLC (effective 2022-11-09).

Action: termination
Agreement: atm program
Counterparty: Jefferies LLC
Effective: 2022-11-09

Exact text from the filing

On October 26, 2022, Zymeworks Inc. (the “Company”) notified Jefferies LLC (“Jefferies”) of its decision to terminate the Open Market Sale Agreement SM , dated as of October 21, 2022, (the “Sales Agreement”) between the Company and Jefferies, effective as of November 9, 2022.

View on SEC.gov

24 material agreements filed in the last 30 days. Browse all material agreements →

Zymeworks Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-272531

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.